Repare Therapeutics RPTX reported its Q3 earnings results on Thursday, November 9, 2023 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Repare Therapeutics beat estimated earnings by 47.67%, reporting an EPS of $-0.45 versus an estimate of $-0.86.
Revenue was down $110.39 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.5 which was followed by a 17.1% increase in the share price the next day.
Here's a look at Repare Therapeutics's past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.78 | -0.81 | -0.97 | -0.89 |
| EPS Actual | -0.28 | -0.83 | -0.75 | 1.71 |
| Revenue Estimate | 7.68M | 6.12M | 10.83M | 1.58M |
| Revenue Actual | 30.25M | 5.68M | 18.20M | 112.55M |
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Repare Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
